Phillips 66 Partners (PSXP) PT Raised to $62 at JPMorgan
- Wall St rises as jobless claims fall; Cigna weighs on healthcare stocks
- Moderna (MRNA) Tops Q2 Street Estimates, Nabs $4.2 Billion from 199 Million Sold Vaccines That Yielded 93% Efficacy Through Six Months
- Oil rises over 1% as Mideast tensions face virus concerns
- Penn National Gaming (PENN) 'Scores' with $2 Billion Deal to Acquire theScore (SCR), Seen as 'Highly Strategic'
- Uber (UBER) Beats Estimates As Higher Labor Spend Drags on Profitability, Analysts Lower PTs but Remain Bullish
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
JPMorgan analyst Jeremy Tonet raised the price target on Phillips 66 Partners (NYSE: PSXP) to $62.00 (from $60.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phillips 66 Partners (PSXP) PT Lowered to $40 at Mizuho Securities
- BP Plc. (BP:LN) (BP) PT Raised to GBP3.10 at Berenberg
- Verbund AG (VER:AV) (OEZVY) PT Raised to EUR85 at Berenberg
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!